In the present study, we mainly found plasma Wnt2b levels in AD patients were decreased and positively correlated with cognitive function, and explored the pathological mechanism of Wnt2b in Alzheimer's disease in vitro and in vivo. Here, WNT2B is linked to early-onset autosomal dominant Alzheimer disease.